News

Roche: Forget Tariffs And Focus On The Positives -- There Are Many
Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...
The Pharma Letter1d
Roche-Zealand alliance could shake up obesity market
The obesity drug market has experienced a seismic shift in recent years, with Novo Nordisk's (NOV: N) Wegovy (semaglutide) ...
Zealand Pharma Goes on Hiring Spree as It Gears Up for Obesity Tie-Up With Roche
The Danish biotech’s recruitment drive began last summer when data from an early-stage trial of the drug—petrelintide—showed ...
Biocon Biologics gets FDA nod for Roche's bevacizumab biosimilar
Biocon Biologics, a subsidiary of India-based Biocon Ltd, said on Thursday that U.S. FDA has approved Jobevne, a biosimilar ...
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
Investors are nervous. As of 9:55 a.m. ET Wednesday morning, shares of Roche Holding ( RHHBY -2.81%) are down 2.3%, Eli Lilly ( LLY -4.38%) stock is off 3.2%, and AstraZeneca ( AZN -4.87%) is doing ...
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Roche Holding AG (OtherRHHVF) and AstraZeneca (AZN)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on United Therapeutics (UTHR – Research ...